AgriFutures Tea Tree Oil Program RD&E Snapshot
Message from the Research Manager, Stephen Taylor As we head into a new research, development and extension (RD&E) period for the AgriFutures Tea Tree Oil...
50 pages
Published: 29 Jun 2010
Author(s): Greay, S, Carson, Christine, Beilharz, Mangred, Kissick, Haydn, Ireland, Demelza, Riley, Thomas
Download report PDF
DownloadPurchase a hard copy - AUD $45.00
The aims of this study were to examine the in vitro anticancer efficacy of Tea Tree Oil and its components against cancer and normal cell lines and to examine the in vivo efficacy of TTO as a potential antitumor agent using mouse mesothelioma and mouse melanoma models.
This RIRDC report discusses data obtained on the in vitro activity of Tea Tree Oil, specifically by significantly reducing viability of malignant mesothelioma and melanoma cells compared with normal human fibroblasts cells in a dose- and time-dependent manner.